The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates.

[1]  J. Monk,et al.  A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use , 2012 .

[2]  M. L. Gilbert,et al.  Tobramycin in ophthalmology. , 1987, Survey of ophthalmology.

[3]  M. Trousdale,et al.  Potential of Topical Norfloxacin Therapy: Comparative In Vitro Activity Against Clinical Ocular Bacterial Isolates , 1987 .

[4]  F. Mégraud,et al.  Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin. , 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[5]  A. Speciale,et al.  The sensitivity of gram-negative and gram-positive bacteria to ofloxacin. , 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[6]  E. Debbia,et al.  Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin. , 1987, Drugs under experimental and clinical research.

[7]  N. Brown,et al.  Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerases. , 1986, Drugs under experimental and clinical research.

[8]  H. Neu,et al.  In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. , 1985, The Journal of antimicrobial chemotherapy.

[9]  I. Phillips,et al.  The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. , 1985, The Journal of antimicrobial chemotherapy.

[10]  G. Ridgway,et al.  The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae. , 1985, Drugs under experimental and clinical research.

[11]  H. Gadebusch,et al.  In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens. , 1985, Chemotherapy.

[12]  S. Mitsuhashi,et al.  In vitro and in vivo activity of DL-8280, a new oxazine derivative , 1982, Antimicrobial Agents and Chemotherapy.